We are committed to finding a safe, effective, and patient-friendly therapy for food and pediatric allergy patients



Latest News

DBV Technologies Highlights Poster Presentations on EPIT® at the 2017 EAACI Congress

DBV Technologies Announces Appointment of Julie O’Neill to Board of Directors


20F- Form 2016

EAACI Congress 2016

The EAACI (European Academy Allergy and Clinical Immunology) Congress took place in Vienna from June 11th to 15th.

Epicutaneous Immunotherapy